7654465111

List of Trials

Send Us A Message

Have questions for us? Contact us to find out more.

  • This field is for validation purposes and should be left unchanged.

Myelofibrosis

April 12, 2019

  • Constellation-0610-02- A Phase 1/2 Study of CPI-0610, a Small Molecule Inhibitor of BET Proteins: Phase 1 (Dose Escalation of CPI-0610 in Patients with Hematological Malignancies) and Phase 2 (Dose Expansion of CPI-0610 with and without Ruxolitinib in Patients with Myelofibrosis)